Neil Bhalodkar - Axonics Modulation Vice Relations

Executive

Neil Bhalodkar is Vice Relations of Axonics Modulation Technologies
Phone949 396 6322
Webhttps://www.axonics.com

Axonics Modulation Management Efficiency

Axonics Modulation's management efficiency ratios could be used to measure how well Axonics Modulation manages its routine affairs as well as how well it operates its assets and liabilities.
Axonics Modulation Technologies currently holds 27.62 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Axonics Modulation has a current ratio of 10.28, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Axonics Modulation's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Christopher LewisGlaukos Corp
N/A
Irene ThomasNeuropace
55
Richard GlazeCONMED
59
Chad PattersoniRhythm Technologies
42
Mathieu AussermeierIntegra LifeSciences Holdings
N/A
Kimberly LockwoodCONMED
N/A
Julie AndrewsOrthofix Medical
54
Stephen LeonardIntegra LifeSciences Holdings
63
Noga ShabshinNano X Imaging
N/A
John WebbLivaNova PLC
N/A
Ruth FlemingIntegra LifeSciences Holdings
N/A
John FerrellCONMED
56
Mark PloofMedtronic PLC
N/A
Thierry PietonMedtronic PLC
55
Daniel EsqCONMED
60
Daniel WilsoniRhythm Technologies
42
Gregory SmithMedtronic PLC
61
Frank VizesiOrthofix Medical
N/A
Justin WardBruker
N/A
Joel BattsOrthopediatrics Corp
N/A
Ray GarrisonOrthopediatrics Corp
N/A
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation systems. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. Axonics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 517 people. Axonics Modulation Technologies (AXNX) is traded on NASDAQ Exchange in USA and employs 797 people.

Management Performance

Axonics Modulation Leadership Team

Elected by the shareholders, the Axonics Modulation's board of directors comprises two types of representatives: Axonics Modulation inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Axonics. The board's role is to monitor Axonics Modulation's management team and ensure that shareholders' interests are well served. Axonics Modulation's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Axonics Modulation's outside directors are responsible for providing unbiased perspectives on the board's policies.
Alfred Ford, Chief Commercial Officer
Danny Dearen, Chief Operating and Financial Officer
MD MAS, Chief Officer
Raymond Cohen, CEO, Director
Rinda Sama, Chief Officer
JD Esq, General VP
Aaron Pettit, General Officer
Kari Keese, Chief Officer
John Woock, Chief Marketing Officer
Neil Bhalodkar, Vice Relations
Guangqiang Jiang, Chief Officer

Axonics Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Axonics Modulation a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in Axonics Stock

If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio